Moreover, parenteral administration of cytotoxic ceramides produces sustained impairments in spatial learning and memory with neurodegeneration and brain insulin/IGF resistance, similar to the effects of DIO with T2DM and NASH [146]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.